Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis

Cytokine

Volumn 50, Issue 2, 2010, Pages 114-116

  Soto Sánchez, Javier ^a   Santos Juanes, Jorge ^a   Coto Segura, Pablo ^a   Coto, Eliecer ^a   Díaz, Marta ^a   Rodríguez, Isabel ^a   Alvarez, Victoria ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Arthritis; Chemokine receptors; Gene polymorphism; Psoriasis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE CLUSTER; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; SPAIN;

ARTHRITIS, PSORIATIC; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; RECEPTORS, CCR2; RECEPTORS, CCR5;

EID: 77950866299     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.01.006     Document Type: Article

References (30)

1. Christophers E. Psoriasis: epidemiology and clinical spectrum. Clin Exp Dermatol 2001, 26:314-320.
2. Lew W., Bowcock A.M., Krueger J.G. Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and " Type 1" inflammatory gene expression. Trends Immunol 2004, 25:295-305.
3. Bos J.D., de Rie M.A., Teunissen M.B., et al. Psoriasis: dysregulation of innate immunity. Br J Dermatol 2005, 152:1098-1107.
4. Homey B. Chemokines and inflammatory skin diseases. Adv Dermatol 2005, 21:251-277.
5. Gasparii A.A. Innate and adaptative immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006, 54:S67-80.
6. Nickoloff B.J., Xin H., Nestle F.O., Qin J.Z. The cytokine and chemokine network in psoriasis. Clin Dermatol 2007, 25:568-573.
7. Homey B. Chemokines and inflammatory skin diseases. Adv Dermatol 2005, 21:251-277.
8. Loetscher P., Uguccioni M., Bordoli L., et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998, 391:344-345.
9. Sozzani S., Allavena P., Vecchi A., et al. Chemokines and dendritic cell traffic. J Clin Immunol 2000, 20:151-160.
10. Christopherson K.W., Hromas R.A. Endothelial chemokines in autoimmune diseases. Curr Pharm Des 2004, 10:145-154.
11. Pastore S., Mascia F., Mariotti F., et al. Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004, 14:203-208.
12. Homey B., Dieu-Nosjean M.C., Wiesenborn A., et al. Up-regulation of macrophage inflammatory protein-3alpha/CCL20 and CC Chemokine receptor 6 in psoriasis. J Immunol 2000, 164:6621-6632.
13. Ottaviani C., Nasorri F., Bedini C., et al. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006, 112:1195-1202.
14. De Groot M., Teunissen M.B., Ortonne J.P., et al. Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor. Arch Dermatol Res 2007, 299:305-313.
15. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
16. Fredriksson T., Petterson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978, 157:238-244.
17. Gonzalez P., Alvarez R., Batalla A., et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun 2001, 2:191-195.
18. Alvarez V., López-Larrea C., Coto E. Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 coreceptors) in resistance to HIV-infection and AIDS development among intravenous drug users. Hum Genet 1998, 192:483-486.
19. Gaunt T.R., Rodriguez S., Day I.N. Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics 2007, 8:428.
20. Hizawa N., Yamaguchi E., Furuya K., et al. The role of the C-C chemokine receptor 2 gene polymorphism V64I in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 1999, 159:2021-2023.
21. Szalai C., Csaszar A., Czinner A., et al. Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res 1999, 46:82-84.
22. Petrek M., Drabek J., Kolek V., et al. CC Chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000, 162:1000-1003.
23. Zapico I., Coto E., Rodríguez A., et al. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000, 1:288-289.
24. Dean M., Carrington M., Winkler C. Genetic restriction of HIV-1 infection and progression to AIDS by deletion allele of the CCR5 structural gene. Science 1996, 273:1856-1861.
25. Benkirane M., Jin D.Y., Chun R.F., et al. Mechanism of transdominant inhibition of CCR5 mediated HIV-infection by CCR5-Δ32. J Biol Chem 1997, 272:30603-30606.
26. Smith M.W., Dean M., Carrington M., Winkler C., Huttley G.A., Lomb D.A., et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997, 277:959-965.
27. Lee B., Doranz B.J., Rana S., Yi Y., Mellado M., Frade J.M., et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 1998, 72:7450-7458.
28. Bayley J.P., Baggen J.M., Pouw-Kraan T., Crusius J.B.A., Huizinga T., Verweij C.L. Association between polymorphisms in the human chemokine receptor genes CCR2 and CX3CR1 and rheumatoid arthritis. Tissue Antigens 2003, 62:170-174.
29. Giustizieri M.L., Mascia F., Frezzolini A., De Pità O., Chinni L.M., Giannetti A., et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001, 107:871-877.
30. Ross E.L., D'Cruz D., Morrow W.J. Localized monocyte chemotactic protein-1 production correlates with T cell infiltration of synovium in patients with psoriatic arthritis. J Rheumatol 2000, 27:2432-2443.